Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making
Authors:
- Michael DrummondMDMichael Drummond
- Ruth BrownRBRuth Brown
- A. Mark FendrickAFA. Mark Fendrick
- Pete FullertonPFPete Fullerton
- Peter NeumannPNPeter Neumann
- Rod TaylorRTRod Taylor
- Marco BarbieriMBMarco Barbieri
- 1 July 2003
- journal article
- review article
- Published by Elsevier in Value in Health
- Vol. 6 (4) , 407-416
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Use of Economic Evaluation in Decision Making: What Needs to Change?Value in Health, 2002
- Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health AuthoritiesValue in Health, 2002
- A survey of physician attitudes and practices concerning cost-effectiveness in patient careWestern Journal of Medicine, 2000
- The influence of economic evaluation studies on decision making.Health Policy, 2000
- PDH23: RELEVANCE OF PHARMACOECONOMICS AND HEALTH OUTCOMES INFORMATION TO HEALTH CARE DECISION-MAKERS IN THE UNITED STATESValue in Health, 2000
- Pharmacoeconomics and Clinical Practice GuidelinesPharmacoEconomics, 2000
- Economic evaluation under managed competition: Evidence from the U.K.Social Science & Medicine, 1997
- The View From Managed Care PharmacyHealth Affairs, 1996
- The use of economic evaluation in health care: Australian decision makers' perceptionsHealth Policy, 1995
- The Use of Technology Assessment by Hospitals, Health Maintenance Organizations, and Third-Party Payers in the United StatesInternational Journal of Technology Assessment in Health Care, 1995